drugset / Trial / NCT00334984

Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma

NCT00334984 ↗

RandomizedDouble-blindSupportive care

Summary

RATIONALE: Glutamine may help prevent mucositis, or mouth sores, in patients receiving chemotherapy for sarcoma. It is not yet known whether glutamine is more effective than a placebo in preventing mucositis in patients receiving chemotherapy for sarcoma. PURPOSE: This randomized clinical trial is studying glutamine to see how well it works compared to a placebo in preventing oral mucositis in patients receiving chemotherapy for sarcoma.

Timeline

Start
2007-01
Primary completion
—
Completion
—

Outcome

Outcome not reported

Stopped: “Withdrawn due to inability to reach an acceptable agreement with industry sponsor”

Drugs

EvaluationDrugModalityDoseRoute
Subject Glutamine Other / unclassified — Oral